Close

Acorda Therapeutics (ACOR) Tops Q2 EPS by 16c

August 1, 2013 6:55 AM EDT Send to a Friend
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of $0.25, $0.16 better than the analyst estimate of $0.09. Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login